Genpharmasec Ltd
₹1.11
(-0.89%)
Wed, 11 Mar 2026, 10:54 pm
Process Industries
Chemicals: Specialty
24.5KGenpharmasec Debt to Equity Ratio
| Particulars | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 1460 | 277.71 | 173.01 | 0 | 76.53 | 0 | 83.63 |
| Price to book ratio | 15.66 | 14.75 | 10.73 | 9.91 | 5.62 | 1.85 | 1.61 |
| Price to sales ratio | 902.10 | 17.02 | 10.20 | 5.57 | 3.37 | 2.25 | 3.10 |
| Price to cash flow ratio | 0 | 144.61 | 0 | 0 | 0 | 0 | 22.54 |
| Enterprise value | 3.32B | 2.76B | 2.06B | 1.48B | 862.39M | 520.19M | 1.05B |
| Enterprise value to EBITDA ratio | 0 | 422.37 | 172.57 | 0 | 335.17 | 1130 | 350.56 |
| Debt to equity ratio | 0 | 0 | 0 | 0 | 0.20 | 0.06 | 0.08 |
| Return on equity % | 0 | 4.97 | 6.34 | -1.16 | 7.33 | -0.32 | 1.94 |
Genpharmasec Ltd Debt to Equity Ratio
The Genpharmasec Ltd Debt to Equity Ratio is a key financial metric used by investors to evaluate Genpharmasec Ltd's valuation, profitability, and overall financial performance. Tracking the Genpharmasec Ltd Debt to Equity Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Genpharmasec Ltd (NSE: , BSE: 531592) is currently trading at ₹1.11, with a market capitalization of ₹620.17M. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Genpharmasec Ltd Debt to Equity Ratio is essential for fundamental analysis.
Genpharmasec Ltd Debt to Equity Ratio Current Value
The current Genpharmasec Ltd Debt to Equity Ratio stands at 0.08.
The latest Genpharmasec Ltd Debt to Equity Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Genpharmasec Ltd Debt to Equity Ratio Historical Trend
The Genpharmasec Ltd Debt to Equity Ratio has shown the following historical trend:
- 2024: 0.08
- 2023: 0.06
- 2022: 0.20
- 2021: 0
- 2020: 0
The recent rise in Genpharmasec Ltd Debt to Equity Ratio suggests strengthening valuation trends and improving market sentiment.
What Genpharmasec Ltd Debt to Equity Ratio Indicates for Investors
The Genpharmasec Ltd Debt to Equity Ratio plays a crucial role in understanding the company's financial health and valuation.
The D/E ratio measures financial leverage and balance sheet strength.
Genpharmasec Ltd Debt to Equity Ratio Analysis Summary
The Genpharmasec Ltd Debt to Equity Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Genpharmasec Ltd Debt to Equity Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Genpharmasec Ltd Debt to Equity Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800